Prelude Therapeutics stockholders elect three Class II directors and ratify auditor at 2022 annual meeting

Prelude Therapeutics Inc

Martin Babler elected with 27,034,110 votes for; 54,875 withheld; 1,215,046 broker non-votes.
Julian Baker elected with 25,635,979 votes for; 1,453,006 withheld; 1,215,046 broker non-votes.
Victor Sandor elected with 26,057,360 votes for; 1,031,625 withheld; 1,215,046 broker non-votes.
Ernst & Young ratified as independent auditor for FY2022: 28,293,151 for, 5,385 against, 5,495 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.